Format
Sort by

Send to:

Choose Destination

Results: 2

1.

Economic impact of disease progression following front-line therapy in classical Hodgkin lymphoma.

Yasenchak CA, Tseng WY, Yap M, Rembert D, Patt DA.

Leuk Lymphoma. 2015 Apr 10:1-20. [Epub ahead of print]

PMID:
25860233
2.

Response to rituximab in patients with type II cryoglobulinemia.

Bryce AH, Dispenzieri A, Kyle RA, Lacy MQ, Rajkumar SV, Inwards DJ, Yasenchak CA, Kumar SK, Gertz MA.

Clin Lymphoma Myeloma. 2006 Sep;7(2):140-4.

PMID:
17026826

Supplemental Content

Loading ...
Write to the Help Desk